DB18621InvestigationalProtein Based Therapies
AOC-1020 is an antibody oligonucleotide conjugate, comprised of a human transferrin receptor 1 targeting, effector function null, humanized IgG1 antibody, a MCC maleimide linker, and a double-stranded siRNA oligonucleotide targeting...
- Mechanism
- Curator reviewed
Pharmacologically active on Transferrin receptor protein 1 and Double homeobox protein 4
- Also known as
- An antibody oligonucleotide conjugate, comprised of a human transferrin receptor 1 targeting, effector function null, humanized IgG1 antibody, a MCC maleimide linker, and a double-stranded siRNA oligonucleotide targeting DUX4
- Code names
- AOC-1020
Resolves to
Targets
What you can answer from here — as of July 09, 2026
Which drugs share a target with AOC-1020, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account